[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]
[Skystar Bio-Pharmaceutical Company Announces Third Quarter 2009 Financial Results Company Reports Record Quarterly Revenue of $12.78 Million and Adjusted Net Income of $4.25 Million; and Adjusted EPS of $0.61 Per Share XI'AN, CHINA – November 16, 2009 – Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) THIRD QUARTER 2009 HIGHLIGHTS § Revenue increased 27.1% period over period to $12.78 million. § Gross margin]
[THT HEAT TRANSFER TECHNOLOGY ANNOUNCES Sales revenue increased by 4.83%; Gross profit increased by 88.75% Siping, CHINA November 16, 2009 THT Heat Transfer Technology, Inc. (Currently incorporated as Third Quarter 2009 Financial Highlights Sales revenue increased by 4.83% year-over-year to US$8.80 million Gross profit increased by 88.75% year-over-year to US$4.13 million Operating income increased by 100.35% year-over-year to] [FORM 8-K CURRENT REPORT November 16, 2009 Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 see Item 2.02. Results of Operations and Financial Condition. Item]
[THT HEAT TRANSFER TECHNOLOGY ANNOUNCES Sales revenue increased by 4.83%; Gross profit increased by 88.75% Siping, CHINA November 16, 2009 THT Heat Transfer Technology, Inc. (Currently incorporated as Third Quarter 2009 Financial Highlights Sales revenue increased by 4.83% year-over-year to US$8.80 million Gross profit increased by 88.75% year-over-year to US$4.13 million Operating income increased by 100.35% year-over-year to] [FORM 8-K CURRENT REPORT November 16, 2009 Date of report (Date of earliest event reported): BTHC VIII, INC. Delaware 000-52232 20-5463509 (State or other jurisdiction of (IRS Employer Identification No.) incorporation or organization) THT Industrial Park, No.5 Nanhuan Road, Tiexi District Siping, Jilin Province 136000 Peoples Republic of China 86-434-3265241 see Item 2.02. Results of Operations and Financial Condition. Item]
[Skystar Bio-Pharmaceuticalmpany Announces Third Quarter 2009 Financial Resultsmpany Reports Record Quarterly Revenue of $12.78 Million andjusted Netome of $4.25 Million; andjusted EPS of $0.61 Per Share XI'AN, CHINA November 16, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) THIRD QUARTER 2009 HIGHLIGHTS Revenuereased 27.1% period over period to $12.78 million.]
[Skystar Bio-Pharmaceuticalmpany Announces Third Quarter 2009 Financial Resultsmpany Reports Record Quarterly Revenue of $12.78 Million andjusted Netome of $4.25 Million; andjusted EPS of $0.61 Per Share XI'AN, CHINA November 16, 2009ystar Bio-Pharmaceuticalmpany (NASDAQ:BI) THIRD QUARTER 2009 HIGHLIGHTS Revenuereased 27.1% period over period to $12.78 million.]
[Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results -- Q3 2009 revenue increased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% -- Q3 2009 net income increased 459.2% to $3.1 million with EPS of $0.13 -- Revenue for the first nine months increased 52.5 % to $36.2 million; net income increased 112.9% to $8.8 million with EPS]
[Ever-Glory Reports Third Quarter 2009 Financial Results -- 3Q09 Gross Margin Increased 420 Basis Points YoY to 18.6% -- -- 3Q09 Net Income Increased 200.3% to $1.9 million or $0.14 per diluted share – Nanjing, China, November 9, 2009 because of the global economic slowdown . During the third quarter 2009, net sales decreased 21.8% to $24.9 million from $31.9]
[Biostar Pharmaceuticals, Inc. Announces Record Third Quarter 2009 Financial Results -- Q3 2009 revenue increased 106.3% to $15.6 million; Q3 Gross Margins of 77.0% -- Q3 2009 net income increased 459.2% to $3.1 million with EPS of $0.13 -- Revenue for the first nine months increased 52.5 % to $36.2 million; net income increased 112.9% to $8.8 million with EPS]
[Ever-Glory Reports Third Quarter 2009 Financial Results -- 3Q09 Gross Margin Increased 420 Basis Points YoY to 18.6% -- -- 3Q09 Net Income Increased 200.3% to $1.9 million or $0.14 per diluted share – Nanjing, China, November 9, 2009 because of the global economic slowdown . During the third quarter 2009, net sales decreased 21.8% to $24.9 million from $31.9]
